Liquid biopsy enables genomic profiling in prostate cancer with high success rates. Learn more about its potential as a ...

Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.

Modern technology could help lower barriers to developing therapies for rare diseases, writes Dr. Rowland Illing, chief ...

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

A team at Rice University has built a lab platform that can map the activity of more than 10 million protein variants in a ...

A federally funded study is coming to Minnesota to determine if whole genome sequencing at birth can reduce childhood diseases and deaths while satisfying growing concerns over genetic privacy and ...

New algorithms support Illumina TruPath™ Genome: v4.5 introdues analytical support for TruPath, leveraging algorithmic advances to resolve 15 highly homologous, medically-relevant genes for rare ...

The study offers a valuable resource and integrates multiple complementary datasets to provide insights into regulatory mechanisms, although the conceptual advances are moderate and the central ...

This is a useful study that seeks to elucidate the molecular mechanisms underlying spinal motor circuit assembly. The authors demonstrate that loss of Onecut transcription factors in spinal motor ...